Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Sep;56(3):267–272. doi: 10.1038/bjc.1987.188

Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.

I Nogae 1, J Kikuchi 1, T Yamaguchi 1, M Nakagawa 1, N Shiraishi 1, M Kuwano 1
PMCID: PMC2002191  PMID: 3663474

Abstract

Vitamin A has been shown to potentiate the cytotoxic action of anticancer agents like vincristine (VCR) against drug resistant mouse P388 leukaemia cells. In vitro tests showed enhancement by retinyl acetate of cytocidal activities of VCR against drug-sensitive leukaemia (P388/S) and VCR-resistant leukaemia (P388/VCR) cells in culture; retinyl acetate rather specifically potentiated VCR against cultured P388/VCR cells than P388/S cells. The cellular accumulation of radioactive VCR was significantly enhanced in cultured P388/VCR cells when retinyl acetate was present. The efflux of VCR from drug-resistant cells was blocked by retinyl acetate. The effect of the combination of vitamin A and VCR was also tested in vivo on the life-span of mice bearing P388/S or P388/VCR. Intraperitoneal administration of retinyl palmitate at 41.75 or 83.5 mg kg-1 was effective to potentiate the antileukaemic activity of VCR against P388/S bearing mice, and it also overcame vincristine-resistance in P388/VCR bearing mice.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama S., Masuda A., Tabuki T., Kuwano M., Komiyama S. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A. Gan. 1981 Oct;72(5):742–746. [PubMed] [Google Scholar]
  2. Akiyama S., Shiraishi N., Kuratomi Y., Nakagawa M., Kuwano M. Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. J Natl Cancer Inst. 1986 May;76(5):839–844. [PubMed] [Google Scholar]
  3. Atukorala S., Basu T. K., Dickerson J. W., Donaldson D., Sakula A. Vitamin A, zinc and lung cancer. Br J Cancer. 1979 Dec;40(6):927–931. doi: 10.1038/bjc.1979.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biedler J. L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970 Apr;30(4):1174–1184. [PubMed] [Google Scholar]
  5. Cohen M. H., Carbone P. P. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst. 1972 Apr;48(4):921–926. [PubMed] [Google Scholar]
  6. Cornwell M. M., Gottesman M. M., Pastan I. H. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem. 1986 Jun 15;261(17):7921–7928. [PubMed] [Google Scholar]
  7. Dresser D. W. Adjuvanticity of vitamin A. Nature. 1968 Feb 10;217(5128):527–529. doi: 10.1038/217527a0. [DOI] [PubMed] [Google Scholar]
  8. Fojo A., Akiyama S., Gottesman M. M., Pastan I. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res. 1985 Jul;45(7):3002–3007. [PubMed] [Google Scholar]
  9. Glaser M., Lotan R. Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid. Cell Immunol. 1979 Jun;45(1):175–181. doi: 10.1016/0008-8749(79)90373-3. [DOI] [PubMed] [Google Scholar]
  10. Ibrahim K., Jafarey N. A., Zuberi S. J. Plasma vitamin "A" and carotene levels in squamous cell carcinoma of oral cavity and oro-pharynx. Clin Oncol. 1977 Jun;3(2):203–207. [PubMed] [Google Scholar]
  11. Ikezaki K., Yamaguchi T., Miyazaki C., Ueda H., Kishiye T., Tahara Y., Koyama H., Takahashi T., Fukawa H., Komiyama S. Potentiation of anticancer agents by new synthetic isoprenoids. I. Inhibition of the growth of cultured mammalian cells. J Natl Cancer Inst. 1984 Oct;73(4):895–901. [PubMed] [Google Scholar]
  12. Inaba M., Johnson R. K. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. Biochem Pharmacol. 1978;27(17):2123–2130. doi: 10.1016/0006-2952(78)90284-8. [DOI] [PubMed] [Google Scholar]
  13. Inaba M., Kobayashi H., Sakurai Y., Johnson R. K. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res. 1979 Jun;39(6 Pt 1):2200–2203. [PubMed] [Google Scholar]
  14. Kuwano M., Nakagawa M., Shiraishi N., Yamaguchi T., Kikuchi J., Akiyama S. Techniques to reverse or circumvent drug-resistance in vitro. Prog Clin Biol Res. 1986;223:163–171. [PubMed] [Google Scholar]
  15. LUCY J. A., DINGLE J. T. FAT-SOLUBLE VITAMINS AND BIOLOGICAL MEMBRANES. Nature. 1964 Oct 10;204:156–160. doi: 10.1038/204156a0. [DOI] [PubMed] [Google Scholar]
  16. Lucy J. A. The fusion of biological membranes. Nature. 1970 Aug 22;227(5260):815–817. doi: 10.1038/227815a0. [DOI] [PubMed] [Google Scholar]
  17. Nakagawa M., Akiyama S., Yamaguchi T., Shiraishi N., Ogata J., Kuwano M. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line. Cancer Res. 1986 Sep;46(9):4453–4457. [PubMed] [Google Scholar]
  18. Nakagawa M., Yamaguchi T., Ueda H., Shiraishi N., Komiyama S., Akiyama S., Ogata J., Kuwano M. Potentiation by vitamin A of the action of anticancer agents against murine tumors. Jpn J Cancer Res. 1985 Sep;76(9):887–894. [PubMed] [Google Scholar]
  19. Rogan A. M., Hamilton T. C., Young R. C., Klecker R. W., Jr, Ozols R. F. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science. 1984 Jun 1;224(4652):994–996. doi: 10.1126/science.6372095. [DOI] [PubMed] [Google Scholar]
  20. Safa A. R., Glover C. J., Meyers M. B., Biedler J. L., Felsted R. L. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem. 1986 May 15;261(14):6137–6140. [PubMed] [Google Scholar]
  21. Shiraishi N., Akiyama S., Kobayashi M., Kuwano M. Lysosomotropic agents reverse multiple drug resistance in human cancer cells. Cancer Lett. 1986 Mar;30(3):251–259. doi: 10.1016/0304-3835(86)90049-2. [DOI] [PubMed] [Google Scholar]
  22. Shiraishi N., Akiyama S., Nakagawa M., Kobayashi M., Kuwano M. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells. Cancer Res. 1987 May 1;47(9):2413–2416. [PubMed] [Google Scholar]
  23. Shoemaker R. H., Wolpert-DeFilippes M. K., Kern D. H., Lieber M. M., Makuch R. W., Melnick N. R., Miller W. T., Salmon S. E., Simon R. M., Venditti J. M. Application of a human tumor colony-forming assay to new drug screening. Cancer Res. 1985 May;45(5):2145–2153. [PubMed] [Google Scholar]
  24. Siegfried J. M., Burke T. G., Tritton T. R. Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance. Biochem Pharmacol. 1985 Mar 1;34(5):593–598. doi: 10.1016/0006-2952(85)90251-5. [DOI] [PubMed] [Google Scholar]
  25. Skovsgaard T. Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Res. 1978 Jun;38(6):1785–1791. [PubMed] [Google Scholar]
  26. Tannock I. F., Suit H. D., Marshall N. Vitamin A and the radiation response of experimental tumors: an immune-mediated effect. J Natl Cancer Inst. 1972 Mar;48(3):731–741. [PubMed] [Google Scholar]
  27. Tomita Y., Himeno K., Nomoto K., Endo H., Hirohata T. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice. J Natl Cancer Inst. 1982 May;68(5):823–827. [PubMed] [Google Scholar]
  28. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981 May;41(5):1967–1972. [PubMed] [Google Scholar]
  29. Yamaguchi T., Ikezaki K., Kishiye T., Tahara Y., Koyama H., Takahasi T., Fukawa H., Komiyama S., Akiyama S., Kuwano M. Potentiation of anticancer agents by new synthetic isoprenoids. II. Inhibition of the growth of transplantable murine tumors. J Natl Cancer Inst. 1984 Oct;73(4):903–907. [PubMed] [Google Scholar]
  30. Yamaguchi T., Nakagawa M., Shiraishi N., Yoshida T., Kiyosue T., Arita M., Akiyama S., Kuwano M. Overcoming drug resistance in cancer cells with synthetic isoprenoids. J Natl Cancer Inst. 1986 May;76(5):947–953. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES